Skip to content

The Utility of Oxygen Insufflation During Flexible Fiberoptic Bronchoscope-guided Intubation

The Utility of Oxygen Insufflation During Flexible Fiberoptic Bronchoscope-guided Intubation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02625194
Enrollment
36
Registered
2015-12-09
Start date
2016-01-01
Completion date
2017-09-04
Last updated
2019-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar Spinal Stenosis

Brief summary

This study investigate the utility of continuous oxygen insufflation during fiberoptic bronchoscope-guided intubation. One group receives oxygen via suction channel of fiberoptic bronchoscope during intubation. The other group does not receive oxygen during fiberoptic bronchoscope-guided intubation. Then, the velocity of deoxygenation difference of PaO2(baseline

Detailed description

Fiberoptic bronchoscope-guided intubation is a gold standard for intubation of a patient with anticipating difficult airway. This technique takes several minutes without oxygen supply, which results in hypoxia when it prolonged. If continuous supply of oxygen during procedure improve the oxygenation, we can reduce the risk of hypoxemia and increase the safety margin during procedure.

Interventions

DRUGOxygen

Oxygen is supplied through suction port during bronchoscope-guided intubation.

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* patients who have surgery under general oral endotracheal anesthesia with invasive arterial blood pressure monitoring

Exclusion criteria

* history of lung disease * abnormality in chest x-ray * anticipating difficult intubation * pregnant women * who is unable to understand and agree the consent form

Design outcomes

Primary

MeasureTime frameDescription
Velocity of PaO2 decreasefrom mask removal to 1st manual ventilation after intubation, up to 5 minuteAfter administration of anesthetic agents and manual ventilation of 5 minutes, arterial blood sampling is collected. Then bronchoscope-guided intubation performed and arterial blood sample is collected immediately after the intubation completed. Time for intubation (between 1st and 2nd blood sample) is recorded. The difference of PaO2(before & after intubation) is divided by the time taking for intubation.

Secondary

MeasureTime frameDescription
success of intubation300 sec after the beginning of intubationAfter 1st trial of intubation, the success of intubation is recorded. If it takes more than 300 sec, it will be considered failure.
PaO21. 5 minutes after manual ventilation / 2.right before 1st manual ventilation after intubation, up to 5 minutearterial blood samples are collected before and after intubation.
PaCO21. 5 minutes after manual ventilation / 2.right before 1st manual ventilation after intubation, up to 5 minutearterial blood samples are collected before and after intubation.
pH1. 5 minutes after manual ventilation / 2.right before 1st manual ventilation after intubation, up to 5 minutearterial blood samples are collected before and after intubation.
visual fieldthroughout the intubation with bronchoscope, upto 5 minuteVisual field is evaluated by the blinded observer. It is evaluated as followed;excellent, good, poor, impossible

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026